Therapeutic proteins are the engineered proteins in the laboratory intended for pharmaceutical use.
Geographically, North America is the dominating region in the Therapeutic Protein market owing to the greater research and development work on therapeutic proteins going on in the North America and Europe.

The global Therapeutic Protein market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Therapeutic Protein volume and value at global level, regional level and company level. From a global perspective, this report represents overall Therapeutic Protein market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Therapeutic Protein in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Therapeutic Protein manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Amgen
Abbott Laboratories
AstraZeneca
Baxter International
Boehringer Ingelheim
Chugai Pharmaceutical
Diasome Pharmaceuticals
Eli Lilly
GeneScience Pharmaceuticals
Generex Biotechnology
Genentech

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Monoclonal Antibodies
Erythropoietin
Insulin
Interferon
Human Growth Hormone
Follicle Stimulating Hormone
Blood Clotting Factors

Segment by Application
Pharmaceutical Companies
Healthcare Service Providers
Research Organizations
Academic Research Institutes